{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T23:48:15Z","timestamp":1792453695729,"version":"4.5.0"},"reference-count":119,"publisher":"SAGE Publications","issue":"5","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/journals.sagepub.com\/page\/policies\/text-and-data-mining-license"}],"content-domain":{"domain":["journals.sagepub.com"],"crossmark-restriction":true},"short-container-title":["Journal of Ocular Pharmacology and Therapeutics"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:p>Blood-derived preparations, including autologous or allogenic serum, umbilical cord serum\/plasma, and platelet-rich plasma eye drops, contain various growth factors, cytokines, and immunoglobulins that resemble natural tears. These components play important roles in corneal cell migration, proliferation, and wound healing. Blood-derived eye drops have demonstrated clinical effectiveness across a spectrum of ocular surface conditions, encompassing dry eye disease, Sj\u00f6gren's syndrome, graft-versus-host disease, and neuropathic corneal pain (NCP). Currently, management of NCP remains challenging. The emergence of blood-derived eye drops represents a promising therapeutic approach. In this review, we discuss the benefits and limitations of different blood-derived eye drops, their mechanisms of action, and treatment efficacy in patients with NCP. Several studies have demonstrated the clinical efficacy of autologous serum eye drops in relieving pain and pain-like symptoms, such as allodynia and photoallodynia. Corneal nerve parameters were also significantly improved, as evidenced by increased nerve fiber density, length, nerve reflectivity, and tortuosity, as well as a decreased occurrence of beading and neuromas after the treatment. The extent of nerve regeneration correlated with improvement in patient-reported photoallodynia. Cord plasma eye drops also show potential for symptom alleviation and corneal nerve regeneration. Future directions for clinical practice and research involve standardizing preparation protocols, establishing treatment guidelines, elucidating underlying mechanisms, conducting long-term clinical trials, and implementing cost-effective measures such as scaling up manufacturing. With ongoing advancements, blood-derived eye drops hold promise as a valuable therapeutic option for patients suffering from NCP.<\/jats:p>","DOI":"10.1089\/jop.2023.0155","type":"journal-article","created":{"date-parts":[[2024,4,22]],"date-time":"2024-04-22T15:37:47Z","timestamp":1713800267000},"page":"281-292","update-policy":"https:\/\/doi.org\/10.1177\/sage-journals-update-policy","source":"Crossref","is-referenced-by-count":19,"title":["Blood-Derived Eye Drops for the Treatment of Corneal Neuropathic Pain"],"prefix":"10.1177","volume":"40","author":[{"given":"Ansa","family":"Anam","sequence":"first","affiliation":[{"name":"Department of Ophthalmology, MTI Khyber Teaching Hospital, Peshawar, Pakistan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[{"name":"Cornea and Refractive Surgery Group, Singapore Eye Research Institute, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis","family":"Tong","sequence":"additional","affiliation":[{"name":"Department of Corneal and External Eye Disease, Singapore National Eye Centre, Singapore, Singapore."},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore."},{"name":"Ocular Surface Group, Singapore Eye Research Institute, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5408-0382","authenticated-orcid":false,"given":"Yu-Chi","family":"Liu","sequence":"additional","affiliation":[{"name":"Cornea and Refractive Surgery Group, Singapore Eye Research Institute, Singapore, Singapore."},{"name":"Department of Corneal and External Eye Disease, Singapore National Eye Centre, Singapore, Singapore."},{"name":"Ophthalmology and Visual Sciences Academic Clinical Program, Duke-NUS Medical School, Singapore, Singapore."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"179","published-online":{"date-parts":[[2024,6,17]]},"reference":[{"key":"e_1_3_4_2_2","doi-asserted-by":"publisher","DOI":"10.1001\/archopht.1975.01010020815015"},{"key":"e_1_3_4_3_2","doi-asserted-by":"publisher","DOI":"10.1002\/art.1780270415"},{"key":"e_1_3_4_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.transci.2017.07.023"},{"key":"e_1_3_4_5_2","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2018.00033"},{"key":"e_1_3_4_6_2","doi-asserted-by":"publisher","DOI":"10.1089\/jop.2016.0166"},{"key":"e_1_3_4_7_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672118818943"},{"key":"e_1_3_4_8_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0161-6420(99)90412-8"},{"key":"e_1_3_4_9_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2019.01.009"},{"key":"e_1_3_4_10_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10792-017-0582-7"},{"key":"e_1_3_4_11_2","doi-asserted-by":"publisher","DOI":"10.2147\/IMCRJ.S153918"},{"key":"e_1_3_4_12_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2004.08.040"},{"issue":"2","key":"e_1_3_4_13_2","first-page":"CD009327","article-title":"Autologous serum eye drops for dry eye","volume":"2","author":"Pan Q","year":"2017","unstructured":"Pan Q, , Angelina A, , Marrone M, et al. Autologous serum eye drops for dry eye. Cochrane Database Syst Rev, 2017; 2(2):CD009327.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2003.10.019"},{"key":"e_1_3_4_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200211000-00010"},{"key":"e_1_3_4_16_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.85.10.1188"},{"key":"e_1_3_4_17_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-200111000-00006"},{"key":"e_1_3_4_18_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2011.587935"},{"key":"e_1_3_4_19_2","doi-asserted-by":"publisher","DOI":"10.1590\/S0004-27492008000700010"},{"issue":"1","key":"e_1_3_4_20_2","first-page":"45","article-title":"Autologous serum eye drops improve tear production, both lachrymal flow and stability tests and conjunctival impression cytology with transfer in dry eye disease","volume":"19","author":"Castillo SLV","year":"2021","unstructured":"Castillo SLV, , Mart\u00edn ES, , Frade LJG, et al. Autologous serum eye drops improve tear production, both lachrymal flow and stability tests and conjunctival impression cytology with transfer in dry eye disease. Blood Transfusion, 2021; 19(1):45.","journal-title":"Blood Transfusion"},{"key":"e_1_3_4_21_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.14788"},{"key":"e_1_3_4_22_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.2004.044347"},{"key":"e_1_3_4_23_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1442-9071.2008.01680.x"},{"key":"e_1_3_4_24_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000147"},{"key":"e_1_3_4_25_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2013.824987"},{"key":"e_1_3_4_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.eye.6703079"},{"key":"e_1_3_4_27_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3180645cd7"},{"key":"e_1_3_4_28_2","doi-asserted-by":"publisher","DOI":"10.1111\/aos.12386"},{"key":"e_1_3_4_29_2","doi-asserted-by":"publisher","DOI":"10.1097\/00002030-200001280-00019"},{"key":"e_1_3_4_30_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000000271"},{"key":"e_1_3_4_31_2","doi-asserted-by":"publisher","DOI":"10.4068\/cmj.2014.50.3.82"},{"key":"e_1_3_4_32_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3182580762"},{"key":"e_1_3_4_33_2","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bi.48.070179.001205"},{"key":"e_1_3_4_34_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713689308995765"},{"key":"e_1_3_4_35_2","doi-asserted-by":"publisher","DOI":"10.1096\/fj.12-225185"},{"issue":"2","key":"e_1_3_4_36_2","first-page":"145","article-title":"Targeting growth factor supply in keratopathy treatment: Comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops","volume":"14","author":"Versura P","year":"2016","unstructured":"Versura P, , Buzzi M, , Giannaccare G, et al. Targeting growth factor supply in keratopathy treatment: Comparison between maternal peripheral blood and cord blood as sources for the preparation of topical eye drops. Blood Transfusion, 2016; 14(2):145.","journal-title":"Blood Transfusion"},{"key":"e_1_3_4_37_2","doi-asserted-by":"publisher","DOI":"10.3109\/02713683.2012.717243"},{"key":"e_1_3_4_38_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.87.11.1312"},{"key":"e_1_3_4_39_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.bmt.1705566"},{"key":"e_1_3_4_40_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31820d850f"},{"key":"e_1_3_4_41_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ico.0000183484.85636.b6"},{"key":"e_1_3_4_42_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2006.12.014"},{"key":"e_1_3_4_43_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2019-314859"},{"key":"e_1_3_4_44_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0000000000001257"},{"key":"e_1_3_4_45_2","doi-asserted-by":"publisher","DOI":"10.1111\/trf.13998"},{"key":"e_1_3_4_46_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1537-2995.2008.01665.x"},{"key":"e_1_3_4_47_2","doi-asserted-by":"publisher","DOI":"10.1080\/14712598.2021.1945030"},{"issue":"9","key":"e_1_3_4_48_2","first-page":"3857","article-title":"The potential of using different forms of topical human platelet lysate eye drops to treat ocular surface diseases","volume":"59","author":"Chen LW","year":"2018","unstructured":"Chen LW, , Huang C-T, , Chu H-S, et al. The potential of using different forms of topical human platelet lysate eye drops to treat ocular surface diseases. Investig Ophthalmol Vis Sci, 2018; 59(9):3857.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_49_2","doi-asserted-by":"publisher","DOI":"10.2147\/OPTH.S265701"},{"issue":"6","key":"e_1_3_4_50_2","first-page":"927","article-title":"Comparison between PRP, PRGF and PRF: Lights and shadows in three similar but different protocols","volume":"19","author":"Giannini S","year":"2015","unstructured":"Giannini S, , Cielo A, , Bonanome L, et al. Comparison between PRP, PRGF and PRF: Lights and shadows in three similar but different protocols. Eur Rev Med Pharmacol Sci, 2015; 19(6):927\u2013930.","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"e_1_3_4_51_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.05-0876"},{"key":"e_1_3_4_52_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7302"},{"key":"e_1_3_4_53_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.11-7340"},{"key":"e_1_3_4_54_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.exer.2015.02.016"},{"key":"e_1_3_4_55_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10384-012-0175-y"},{"key":"e_1_3_4_56_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-022-12879-x"},{"key":"e_1_3_4_57_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31829f7088"},{"key":"e_1_3_4_58_2","doi-asserted-by":"publisher","DOI":"10.1177\/1120672117747042"},{"key":"e_1_3_4_59_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2021.09.003"},{"issue":"3","key":"e_1_3_4_60_2","first-page":"403","article-title":"Umbilical cord blood platelet lysate as serum substitute in expansion of human mesenchymal stem cells","volume":"19","author":"Shirzad N","year":"2017","unstructured":"Shirzad N, , Bordbar S, , Goodarzi A, et al. Umbilical cord blood platelet lysate as serum substitute in expansion of human mesenchymal stem cells. Cell J (Yakhteh), 2017; 19(3):403.","journal-title":"Cell J (Yakhteh)"},{"key":"e_1_3_4_61_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.10.001"},{"key":"e_1_3_4_62_2","doi-asserted-by":"publisher","DOI":"10.1097\/00003226-199811000-00002"},{"key":"e_1_3_4_63_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2014-306280"},{"key":"e_1_3_4_64_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2007.10.009"},{"key":"e_1_3_4_65_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.308666"},{"key":"e_1_3_4_66_2","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9123956"},{"key":"e_1_3_4_67_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.327364"},{"key":"e_1_3_4_68_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ophtha.2017.08.004"},{"key":"e_1_3_4_69_2","unstructured":"Moshirfar M Benstead EE Sorrentino PM et al. Ocular Neuropathic Pain. StatPearls Publishing: Treasure Island FL; 2019."},{"key":"e_1_3_4_70_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2015.01.005"},{"key":"e_1_3_4_71_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2016.10.002"},{"key":"e_1_3_4_72_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.15-18133"},{"key":"e_1_3_4_73_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.04-1426"},{"key":"e_1_3_4_74_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.289435"},{"issue":"8","key":"e_1_3_4_75_2","first-page":"965","article-title":"Neuropathic corneal pain: Clinical manifestations, imaging features, tear neuromediators and proteomic profiles","volume":"64","author":"Liu Y-C","year":"2023","unstructured":"Liu Y-C, , Liu C, , Lin MT-Y, et al. Neuropathic corneal pain: Clinical manifestations, imaging features, tear neuromediators and proteomic profiles. Investig Ophthalmol Vis Sci, 2023; 64(8):965.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_76_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2024.03.015"},{"issue":"8","key":"e_1_3_4_77_2","first-page":"2656","article-title":"In vivo confocal microscopy demonstrates the presence of microneuromas and may allow differentiation of patients with corneal neuropathic pain from dry eye disease","volume":"58","author":"Moein H-R","year":"2017","unstructured":"Moein H-R, , Dieckmann G, , Abbouda A, et al. In vivo confocal microscopy demonstrates the presence of microneuromas and may allow differentiation of patients with corneal neuropathic pain from dry eye disease. Investig Ophthalmol Vis Sci, 2017; 58(8):2656.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_78_2","doi-asserted-by":"publisher","DOI":"10.4103\/1673-5374.375308"},{"key":"e_1_3_4_79_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjophthalmol-2020-317891"},{"key":"e_1_3_4_80_2","doi-asserted-by":"publisher","DOI":"10.3109\/08820538.2015.1114853"},{"key":"e_1_3_4_81_2","first-page":"CD006775","article-title":"Punctal occlusion for dry eye syndrome","volume":"6","author":"Ervin AM","year":"2017","unstructured":"Ervin AM, , Law A, , Pucker AD. Punctal occlusion for dry eye syndrome. Cochrane Database Syst Rev, 2017; 6:CD006775.","journal-title":"Cochrane Database Syst Rev"},{"key":"e_1_3_4_82_2","first-page":"299","article-title":"Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop","volume":"7","author":"Coffey MJ","year":"2013","unstructured":"Coffey MJ, , DeCory HH, , Lane SS. Development of a non-settling gel formulation of 0.5% loteprednol etabonate for anti-inflammatory use as an ophthalmic drop. Clin Ophthalmol, 2013; 7:299\u2013312.","journal-title":"Clin Ophthalmol"},{"key":"e_1_3_4_83_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0886-3350(01)01185-3"},{"key":"e_1_3_4_84_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e3181a16472"},{"key":"e_1_3_4_85_2","doi-asserted-by":"publisher","DOI":"10.1097\/ICO.0b013e31823f8c9b"},{"key":"e_1_3_4_86_2","doi-asserted-by":"publisher","DOI":"10.4103\/0976-500X.195920"},{"key":"e_1_3_4_87_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2015.07.003"},{"key":"e_1_3_4_88_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.clae.2013.02.004"},{"key":"e_1_3_4_89_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ajo.2009.07.037"},{"key":"e_1_3_4_90_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0002-9394(00)00378-0"},{"key":"e_1_3_4_91_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2010.09.030"},{"key":"e_1_3_4_92_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2005.08.013"},{"key":"e_1_3_4_93_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1468-1331.2010.02999.x"},{"key":"e_1_3_4_94_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pain.2013.06.004"},{"key":"e_1_3_4_95_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2016.00276"},{"key":"e_1_3_4_96_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpain.2016.01.395"},{"key":"e_1_3_4_97_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(10)70143-5"},{"key":"e_1_3_4_98_2","doi-asserted-by":"publisher","DOI":"10.1016\/S1474-4422(14)70251-0"},{"key":"e_1_3_4_99_2","doi-asserted-by":"publisher","DOI":"10.7326\/0003-4819-136-5-200203050-00010"},{"key":"e_1_3_4_100_2","doi-asserted-by":"publisher","DOI":"10.1111\/ner.12208"},{"key":"e_1_3_4_101_2","doi-asserted-by":"publisher","DOI":"10.3390\/ijms141021167"},{"issue":"13","key":"e_1_3_4_102_2","first-page":"1468","article-title":"Efficacy of autologous serum tears for treatment of severe corneal pain in patients with corneal neuropathy: An in vivo confocal microscopy study","volume":"55","author":"Aggarwal S","year":"2014","unstructured":"Aggarwal S, , Colon CM, , Kheirkhah A, et al. Efficacy of autologous serum tears for treatment of severe corneal pain in patients with corneal neuropathy: An in vivo confocal microscopy study. Investig Ophthalmol Vis Sci, 2014; 55(13):1468.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_103_2","doi-asserted-by":"publisher","DOI":"10.21037\/apm-20-1453"},{"key":"e_1_3_4_104_2","doi-asserted-by":"publisher","DOI":"10.1007\/s10571-009-9430-2"},{"key":"e_1_3_4_105_2","doi-asserted-by":"publisher","DOI":"10.1093\/intimm\/dxh267"},{"key":"e_1_3_4_106_2","doi-asserted-by":"publisher","DOI":"10.3389\/fnmol.2023.1110975"},{"key":"e_1_3_4_107_2","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.717993"},{"issue":"8","key":"e_1_3_4_108_2","first-page":"749","article-title":"Exosomes as a novel multitarget approach to promote growth of corneal sensory neurons","volume":"62","author":"Katz E","year":"2021","unstructured":"Katz E, , Guaiquil VH, , Ivakhnitskaia E, et al. Exosomes as a novel multitarget approach to promote growth of corneal sensory neurons. Investig Ophthalmol Vis Sci, 2021; 62(8):749.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_109_2","doi-asserted-by":"publisher","DOI":"10.1038\/39807"},{"key":"e_1_3_4_110_2","doi-asserted-by":"publisher","DOI":"10.1167\/iovs.62.9.6"},{"key":"e_1_3_4_111_2","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13536-0"},{"key":"e_1_3_4_112_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2023.09.004"},{"key":"e_1_3_4_113_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2022.06.007"},{"key":"e_1_3_4_114_2","article-title":"Use of Trpv1 Receptor Antagonists for Treating Dry Eye and Ocular Pain","author":"Yanni JM","year":"2009","unstructured":"Yanni JM, , Gamache DA. Use of Trpv1 Receptor Antagonists for Treating Dry Eye and Ocular Pain. Google Patents: 2009.","journal-title":"Google Patents"},{"issue":"14","key":"e_1_3_4_115_2","first-page":"3844","article-title":"SYL1001 targeting TRPV1 receptor for the treatment of ocular pain associated to dry eye syndrome","volume":"52","author":"Gonzalez V","year":"2011","unstructured":"Gonzalez V, , J\u00edmenez AI, , Mart\u00ednez T. SYL1001 targeting TRPV1 receptor for the treatment of ocular pain associated to dry eye syndrome. Investig Ophthalmol Vis Sci, 2011; 52(14):3844.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_116_2","doi-asserted-by":"publisher","DOI":"10.1007\/s40265-020-01429-2"},{"key":"e_1_3_4_117_2","doi-asserted-by":"publisher","DOI":"10.2174\/157015908784533888"},{"issue":"8","key":"e_1_3_4_118_2","first-page":"796","article-title":"Modulating ocular surface pain through Neurokinin-1 receptor blockade","volume":"62","author":"Ferrari G","year":"2021","unstructured":"Ferrari G, , Vitar RML, , Fonteyne P, et al. Modulating ocular surface pain through Neurokinin-1 receptor blockade. Investig Ophthalmol Vis Sci, 2021; 62(8):796.","journal-title":"Investig Ophthalmol Vis Sci"},{"key":"e_1_3_4_119_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtos.2017.05.008"},{"key":"e_1_3_4_120_2","doi-asserted-by":"publisher","DOI":"10.1136\/bjo.83.4.390"}],"container-title":["Journal of Ocular Pharmacology and Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.sagepub.com\/doi\/full-xml\/10.1089\/jop.2023.0155","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0155","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/journals.sagepub.com\/doi\/pdf\/10.1089\/jop.2023.0155","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:46:04Z","timestamp":1777646764000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.sagepub.com\/doi\/10.1089\/jop.2023.0155"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":119,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,6,1]]}},"alternative-id":["10.1089\/jop.2023.0155"],"URL":"https:\/\/doi.org\/10.1089\/jop.2023.0155","relation":{},"ISSN":["1080-7683","1557-7732"],"issn-type":[{"value":"1080-7683","type":"print"},{"value":"1557-7732","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}